Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
Shicai Liu, Jinke Wang
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 6, pp. 2695-2709
Open Access | Times Cited: 25

Showing 25 citing articles:

SERSomes for metabolic phenotyping and prostate cancer diagnosis
Xinyuan Bi, Jiayi Wang, Bingsen XUE, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101579-101579
Open Access | Times Cited: 17
Minimal residue disease detection in early-stage breast cancer: a review
Yuan Zhang, Xiao‐Ying Yuan
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Artificial Intelligence in Genetics
Mark A Sanders
Legal medicine (2024), pp. 38-43.e2
Closed Access | Times Cited: 7
Liquid Biopsies: Emerging role and clinical applications in solid tumours
Sandeep Sisodiya, Vishakha Kasherwal, Asiya Khan, et al.
Translational Oncology (2023) Vol. 35, pp. 101716-101716
Open Access | Times Cited: 14
Circulating tumor DNA in liquid biopsy: Current diagnostic limitation
Shicai Liu
World Journal of Gastroenterology (2024) Vol. 30, Iss. 15, pp. 2175-2178
Open Access | Times Cited: 5
Liquid Biopsy for Oral Cancer Diagnosis: Recent Advances and Challenges
Yutaka Naito, Kazufumi Honda
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 303-303
Open Access | Times Cited: 12
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer
Chiara Reina, Berina Šabanović, Chiara Lazzari, et al.
Translational research (2024) Vol. 272, pp. 41-53
Closed Access | Times Cited: 4
CRISPR-Cas12a based detection of EGFR gene mutation in cell free DNA for early diagnosis of non-small cell lung cancer (NSCLC)
Syeda Najidah Shahni, Sarah Albogami, Bijay Pattnaik, et al.
Sensing and Bio-Sensing Research (2025), pp. 100735-100735
Open Access
A wearable device for continuous monitoring of circulating cells at single-cell resolution
Kyuho Jang, Shivam N. Kajale, Baju Joy, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Plasma Mycobacterium tuberculosis cell-free DNA assay: a diagnostic tool for tuberculosis lymphadenitis
Sosina Ayalew, Teklu Wegayehu, Biniam Wondale, et al.
Infectious Diseases (2025), pp. 1-13
Closed Access
Detection of neuron-derived cfDNA in blood plasma: a new diagnostic approach for neurodegenerative conditions
Chad Pollard, Kenneth I. Aston, Benjamin R. Emery, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 10
Advancements in Heart Transplantation: Donor-Derived Cell-Free DNA as Next-Generation Biomarker
Paweł Borkowski, Nikita Singh, Natalia Borkowska
Cureus (2024)
Open Access | Times Cited: 3
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer
Akash Bararia, Prosenjeet Chakraborty, Paromita Roy, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 15, pp. 2241-2260
Open Access | Times Cited: 8
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
Eun-Ji Choi, Young-Joon Kim
Journal of Liver Cancer (2022) Vol. 22, Iss. 2, pp. 103-114
Open Access | Times Cited: 9
Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects
Alina O. Penkova, Olga Kuziakova, Valeriia Gulaia, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 4
Analysis of urine cell-free DNA in bladder cancer diagnosis by emerging bioactive technologies and materials
Feifei Huang, Xiao-Fei Di, Mo-Han Bai
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 1
Application of graft-derived cell-free DNA for solid organ transplantation
Wenqiang Zhang, Bin Liu, Dan Jia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Detection of Neuron-Derived cfDNA in Blood Plasma: A New Diagnostic Approach for Neurodegenerative Conditions
Chad Pollard, Kenneth I. Aston, Benjamin R. Emery, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value
Somayeh Igder, Mozhdeh Zamani, Shima Fakher, et al.
Disease Markers (2024) Vol. 2024, pp. 1-25
Open Access
Quantitative Peripheral Live Single T-Cell Dynamic Polyfunctionality as a Predictive Biomarker in Cancer Immunotherapy
Zuan-Fu Lim, Xiaoliang Wu, Lin Zhu, et al.
(2024)
Open Access
Personalized Molecular Therapies for Advanced Non-Small Cell Lung Cancer: Overcoming Heterogeneity to Optimize Treatment Response and Clinical Outcomes
Zuan-Fu Lim
(2024)
Open Access
Early diagnostic strategies for colorectal cancer
Shicai Liu, Han Zhang
World Journal of Gastroenterology (2024) Vol. 30, Iss. 33, pp. 3818-3822
Closed Access
Crispr-Cas12a Based Detection of Egfr Gene Mutation in Cell Free DNA for Early Diagnosis of Non-Small Cell Lung Cancer (Nsclc)
Syeda Najidah Shahni, Sarah Albogami, Bijay Pattnaik, et al.
(2024)
Closed Access
Considering Biomarkers of Neurodegeneration in Alzheimer’s Disease: The Potential of Circulating Cell-Free DNA in Precision Neurology
Chad Pollard, Erin R. Saito, Jeffrey M. Burns, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1104-1104
Open Access
Incidental Detection of Malignancies With Cell-Free DNA Screening
B Rink, Blair Stevens
Clinical Obstetrics & Gynecology (2023) Vol. 66, Iss. 3, pp. 607-615
Closed Access
Page 1

Scroll to top